English
-
FDA Approves Vyjuvek
Mon May 22 10:33:59 CST 2023
May 19, 2023, the U.S. Food and Drug Administration approved Vyjuvek, a herpes-simplex virus type 1 (HSV-1) vector-based gene therapy, for the treatment of wounds in patients 6 months of age and older with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene. -
-
-
-
-
Material Features of PETG media bottles
Tue May 09 10:36:46 CST 2023
PETG media bottles have very good gas barrier properties, and are often used to store and sample active pharmaceutical ingredients and bulk intermediates, and are also very suitable for preparing and storing buffers, serum, various culture media and other liquids.
Send Inquiry